Publication | Closed Access
STUDIES ON THE AROMATISATION OF NEUTRAL STEROIDS IN PREGNANT WOMEN
114
Citations
0
References
1964
Year
Hormonal ContraceptiveReproductive HealthGynecologyTherapeutic AbortionFemale Reproductive FunctionEmbryologyReproductive EndocrinologyFemale InfertilityReproductive MedicineUrine SamplesPublic HealthSteroid MetabolismMaternal HealthPlacental DiseaseAromataseEndocrinologyPharmacologyPlacental FunctionEndocrine DisruptorsAbortionPhenolic MaterialUterine ReceptivityMedicineEndocrine ResearchWomen's Health
ABSTRACT In 15 cases of therapeutic abortion by laparotomy the placenta was disconnected from the foetus and perfused in situ with tracer amounts of radioactive dehydro epi androsterone (DHA), dehydro epi androsterone sulphate (DHAS), androst-4-ene-3,17-dione (A), testosterone (T) and 17β-oestradiol (OE 2 ). Analysis of the placentas, perfusates and urine samples revealed an extensive aromatisation of DHA, A and T; more than 70% of the radioactive material recovered was phenolic, and at least 80 % of this phenolic material was identified as oestrone (OE 1 ), 17β-oestradiol (OE 2 ) and oestriol (OE 3 ), the latter being detected only in the urine. Comparative studies indicated that A and T were aromatised somewhat better than DHA and that all three unconjugated steroids were aromatised to a much greater extent than DHAS. Radioactive OE 1 and OE 2 were isolated and identified in the placentas and perfusates, but no OE 3 , epimeric oestriols, or ring D ketols could be detected in these sources, not even when human chorionic gonadotrophin (HCG) was added to the blood prior to perfusion. Lack of placental 16-hydroxylation was also apparent when OE 2 was perfused. Regardless of the precursor perfused, there was three times more OE 2 than OE 1 in the placenta and three times more OE 1 than OE 2 in the perfusate. This was also the case following perfusion with OE 2 . The results are interpreted as suggesting the existence in the pregnant human of a placental »barrier« limiting the passage of circulating androgen. The barrier consists of a) limited ability to transfer directly DHAS and b) an enzymic mechanism resulting in the rapid and extensive aromatisation of the important androgens DHA, A and T.